GoldenGolden
VI Partners

VI Partners

A venture capital and private equity firm investing in healthcare, biotechnology, and software companies.

All edits by  Carla Faraguna 

Edits on 23 Jan, 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+8/-8 characters)
Article

VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies that is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, NovartisNovartis, Credit Suisse, and Nestle.

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+11/-11 characters)
Article

VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies that is headquartered in Altendorf, SwitzerlandSwitzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, Novartis, Credit Suisse, and Nestle.

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+13/-13 characters)
Article

VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies that is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, Novartis, Credit SuisseCredit Suisse, and Nestle.

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+4/-4 characters)
Article

VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies that is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, SuvaSuva, Buhler, Novartis, Credit Suisse, and Nestle.

Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+11/-11 characters)
Article

VI Partners typically invests in early and growth-stage biotechnology, healthcare, and software companies. As of November 2019 the firm has made 91 investments, has 24 companies in its portfolio, and has made 29 exits. Notable investments made by VI Partners include: Avalon Photonics, Deal United, EpiSpeed, Hybris Software, Mesa Imaging, Mila, Nexthink, PicoDRILL, Visonys, Activaero, Endoart Medical Technologies, Endo Sense, Neocutis, Neogym, Oncalis, Spinelab, Thommen Medical, Xigen, Edimer, Kuros Biosciences, Ventaleon, Gamaya, Ledgy, Myotest, Senbiosys, Sonic Emotion, and Smart ValorSmart Valor.

Carla Faraguna
Carla Faraguna edited on 23 Jan, 2020
Edits made to:
Article (+2/-27 characters)
Article

VI Partners typically invests in early and growth-stage biotechnology, healthcare, and software companies. According to Pitchbook (asAs of November 2019) the firm has made 91 investments, has 24 companies in its portfolio, and has made 29 exits. Notable investments made by VI Partners include: Avalon Photonics, Deal United, EpiSpeed, Hybris Software, Mesa Imaging, Mila, Nexthink, PicoDRILL, Visonys, Activaero, Endoart Medical Technologies, Endo Sense, Neocutis, Neogym, Oncalis, Spinelab, Thommen Medical, Xigen, Edimer, Kuros Biosciences, Ventaleon, Gamaya, Ledgy, Myotest, Senbiosys, Sonic Emotion, and Smart Valor.

Edits on 14 Nov, 2019
Carla Faraguna
Carla Faraguna edited on 14 Nov, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.